
Please try another search
Health Ever Biotech Co., Ltd., a biotechnology company, focuses on the research and development of new botanical drug products. The company’s lead product is MCS-2, which is being studied in Phase III clinical trials for the treatment of benign prostate hyperplasia and other diseases. It also develops MCS-5 and MCS-8 that are in Phase II clinical trials. Health Ever Biotech Co., Ltd. is based in Taipei City, Taiwan. Health Ever Biotech Co., Ltd. operates as a subsidiary of Jyong Biotech Ltd.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review